Oriental Pharmacy and Experimental Medicine

, Volume 11, Issue 4, pp 243–249 | Cite as

Pre clinical studies of Streblus asper Lour in terms of behavioural safety and toxicity

  • R. B. Suresh KumarEmail author
  • A. Puratchikodi
  • Angelene Prasanna
  • Narayan Dolai
  • Piyali Majumder
  • U. K. Mazumder
  • P. K. Haldar
Research Article


Streblus asper Lour (Family: Moraceae) is a medicinal plant wildly grows in most part of Asian countries. It has many traditional uses like leprosy, piles, diarrhoea, dysentery, elephantiasis, cancer etc. This present study was relates in terms of behavioural safety and toxicity studies of methanol and petroleum ether extracts of S. asper. Brine Shrimps lethality bioassay method was established for the present study and cytotoxicity was reported in terms of 50% lethality concentration (LC50). Different concentrations of drug solutions were added to the Brine Shrimps, surviving shrimps were counted after 24 h and 50% lethality concentration (LC50) were assessed. Acute toxicity was studied on Swiss albino mice after single dose. Sub-Chronic toxicity was performed for 28 days and assessed with biochemical and histopathological parameters. On cytotoxicity studies of brine shrimps it was found methanol extract of S. asper (MESA) was weakly toxic, may be due to the presence of cardiac glycosides and bioactive compounds, however petroleum ether extract of S. asper (PESA) was non toxic. But, in case of acute and sub-acute toxicity study both extracts were found to be non-toxic.


Streblus asper Cytotoxicity Brine shrimps Acute toxicity Sub-chronic toxicity 



This work was fully funded by University Grants Commission (U.G.C), Grant number P-1\RS\115\2010, New Delhi, India. This funding had no role in the collection, analysis and interpretation of data or in the writing of the manuscript.


  1. Alam M (1992) Medical ethnobotany of the Marma tribe of Bangladesh. Econ Bot 46:330–335. doi: 10.1007/BF02866632 CrossRefGoogle Scholar
  2. Barahona M, Sanchez-Fortun S (1999) Toxicity of carbamates to the brine shrimp Artemia salina and the effect of atropine, BW284c51, iso-OMPA and 2-PAM on carbaryl toxicity. Environ Pollut 104:469–476. doi: 10.1016/S0269-7491(98)00152-3 CrossRefGoogle Scholar
  3. Bhandary M, Chandrashekar K, Kaveriappa K (1995) Medical ethnobotany of the siddis of Uttara Kannada district, Karnataka, India. J Ethnopharmacol 47:149–158PubMedCrossRefGoogle Scholar
  4. Cepleanu F, Hamburger M, Sordat B, Msonthi J, Gupta M, Saadou M, Hostettmann K (1994) Screening of tropical medicinal plants for molluscicidal, larvicidal, fungicidal and cytotoxic activities and brine shrimp toxicity. Pharm Biol 32:294–307CrossRefGoogle Scholar
  5. Chan K (2003) Some aspects of toxic contaminants in herbal medicines. Chemosphere 52:1361–1371PubMedCrossRefGoogle Scholar
  6. Deciga-Campos M, Rivero-Cruz I, Arriaga-Alba M, Castaneda-Corral G, Angeles-Lopez GE, Navarrete A, Mata R (2007) Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. Journal of ethnopharmacology 110:334–342PubMedCrossRefGoogle Scholar
  7. Fennell C, Lindsey K, McGaw L, Sparg S, Stafford G, Elgorashi E, Grace O, Van Staden J (2004) Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology. J Ethnopharmacol 94:205–217PubMedCrossRefGoogle Scholar
  8. Fiebig M, Duh CY, Pezzuto JM, Kinghorn AD, Farnsworth NR (1985) Plant anticancer agents, XLI. Cardiac glycosides from Streblus asper. J Nat Prod 48:981–985PubMedCrossRefGoogle Scholar
  9. Gupta M, Monge A, Karikas G, Lopez de Cerain A, Solis P, De Leon E, Trujillo M, Suarez O, Wilson F, Montenegro G (1996) Screening of Panamanian medicinal plants for brine shrimp toxicity, crown gall tumor inhibition, cytotoxicity and DNA intercalation. Pharm Biol 34:19–27CrossRefGoogle Scholar
  10. Kostis JB, Turkevich D, Sharp J (1984) Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 53:997–999PubMedCrossRefGoogle Scholar
  11. Lapornik B, Prosek M, Golc Wondra A (2005) Comparison of extracts prepared from plant by-products using different solvents and extraction time. J Food Eng 71:214–222CrossRefGoogle Scholar
  12. Malek D, Malley L, Slone T, Elliott G, Kennedy G, Mellert W, Deckardt K, Gembardt C, Hildebrand B, Murphy S (1997) Repeated dose toxicity study (28 days) in rats and mice with N-methylpyrrolidone (NMP). Drug Chem Toxicol 20:63–77PubMedCrossRefGoogle Scholar
  13. Meyer B, Ferrigni N, Putnam J, Jacobsen L, Nichols D, McLaughlin J (1982) Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med 45:31–34CrossRefGoogle Scholar
  14. Michael A, Thompson C, Abramovitz M (1956) Artemia salina as a test organism for bioassay. Science 123:464PubMedCrossRefGoogle Scholar
  15. Mongelli E, Martino V, Coussio J, Ciccia G (1996) Screening of Argentine medicinal plants using the brine shrimp microwell cytotoxicity assay. Pharm Biol 34:249–254CrossRefGoogle Scholar
  16. Pelka M, Danzl C, Distler W, Petschelt A (2000) A new screening test for toxicity testing of dental materials. J Dent 28:341–345PubMedCrossRefGoogle Scholar
  17. Rastogi S, Kulshrestha DK, Rawat AKS (2006) Streblus asper Lour. (Shakhotaka): a review of its chemical, pharmacological and ethnomedicinal properties. Evid Based Complement Alternat Med 3(2):217–222. doi: 10.1093/ecam/nel018 CrossRefGoogle Scholar
  18. Solis PN, Wright CW, Anderson MM, Gupta MP, Phillipson JD (1993) A microwell cytotoxicity assay using Artemia salina (brine shrimp). Planta Med 59:250–250PubMedCrossRefGoogle Scholar

Copyright information

© Institute of Oriental Medicine, Kyung Hee University 2011

Authors and Affiliations

  • R. B. Suresh Kumar
    • 1
    Email author
  • A. Puratchikodi
    • 3
  • Angelene Prasanna
    • 1
  • Narayan Dolai
    • 4
  • Piyali Majumder
    • 1
  • U. K. Mazumder
    • 1
  • P. K. Haldar
    • 1
    • 2
  1. 1.Division of Pharmacology, Department of Pharmaceutical TechnologyJadavpur UniversityKolkata-32India
  2. 2.Department of PharmacologyHimalayan Pharmacy InstituteMajhitar, RangpoIndia
  3. 3.Department of Pharmaceutical, Engineering and TechnologyAnna University TrichyTrichy-24India
  4. 4.National Institute of Pharmaceutical Educations & ResearchKolkata-32India

Personalised recommendations